Catalyst Wire Dossier Catalyst Wire Dossier

Truvada (emtricitabine/tenofovir disoproxil fumarate)

emtricitabine/tenofovir disoproxil fumarate · Gilead Sciences
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Truvada (emtricitabine/tenofovir disoproxil fumarate), covering 2025-06-24 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Implementing PrEP for Women Who Inject Drugs [NA]

See pricing